This guidance clarifies the requirements for product name placement, size, prominence, and frequency2 in promotional labeling and advertisements for prescription drugs.3 The disclosure of the product name in promotional labeling and advertisements is important for proper identification and to ensure safe and effective use. This guidance also articulates the circumstances under which FDA intends to refrain from taking enforcement action regarding these requirements. We believe that following this guidance will allow for appropriate advertising and promotion without presenting any public health risk to patients.